> top > docs > PubMed:26270232 > annotations

PubMed:26270232 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-113 Sentence denotes Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
T2 114-125 Sentence denotes BACKGROUND:
T3 126-199 Sentence denotes Most hepatocellular carcinomas (HCCs) are diagnosed at an advanced stage.
T4 200-320 Sentence denotes The prognostic value of serum tumour markers alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) is limited.
T5 321-483 Sentence denotes The aim of our study is to evaluate the diagnostic value of serum growth factors, apoptotic and inflammatory mediators of cirrhotic patients with and without HCC.
T6 484-492 Sentence denotes METHODS:
T7 493-659 Sentence denotes Serum samples were collected from cirrhotic potential liver transplant patients (LTx) with (n=61) and without HCC (n=78) as well as from healthy controls (HCs; n=39).
T8 660-927 Sentence denotes Serum concentrations of CRP, neopterin and IL-6 as markers of inflammation and thrombopoietin (TPO), GCSF, FGF basic and VEGF, HMGB1, CK-18 (M65) and CK18 fragment (M30) and a panel of proinflammatory chemokines (CCL2, CCL3, CCL4, CCL5, CXCL5 and IL-8) were measured.
T9 928-1058 Sentence denotes Chi square, Fisher exact, Mann-Whitney U-tests, ROC curve analysis and forward stepwise logistic regression analyses were applied.
T10 1059-1067 Sentence denotes RESULTS:
T11 1068-1230 Sentence denotes Patients with HCC had higher serum TPO and chemokines (P<0.001 for TPO, CCL4, CCL5 and CXCL5) and lower CCL2 (P=0.008) levels than cirrhotic patients without HCC.
T12 1231-1403 Sentence denotes Multivariate forward stepwise regression analysis for significant parameters showed that among the studied parameters CCL4 and CCL5 (P=0.001) are diagnostic markers of HCC.
T13 1404-1522 Sentence denotes Serum levels of TPO and chemokines were lower, whereas M30 was significantly higher in cirrhotic patients than in HCs.
T14 1523-1535 Sentence denotes CONCLUSIONS:
T15 1536-1667 Sentence denotes High serum levels of inflammatory chemokines such as CCL4 and CCL5 in the serum of cirrhotic patients indicate the presence of HCC.
T1 0-113 Sentence denotes Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
T2 114-125 Sentence denotes BACKGROUND:
T3 126-199 Sentence denotes Most hepatocellular carcinomas (HCCs) are diagnosed at an advanced stage.
T4 200-320 Sentence denotes The prognostic value of serum tumour markers alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) is limited.
T5 321-483 Sentence denotes The aim of our study is to evaluate the diagnostic value of serum growth factors, apoptotic and inflammatory mediators of cirrhotic patients with and without HCC.
T6 484-492 Sentence denotes METHODS:
T7 493-659 Sentence denotes Serum samples were collected from cirrhotic potential liver transplant patients (LTx) with (n=61) and without HCC (n=78) as well as from healthy controls (HCs; n=39).
T8 660-927 Sentence denotes Serum concentrations of CRP, neopterin and IL-6 as markers of inflammation and thrombopoietin (TPO), GCSF, FGF basic and VEGF, HMGB1, CK-18 (M65) and CK18 fragment (M30) and a panel of proinflammatory chemokines (CCL2, CCL3, CCL4, CCL5, CXCL5 and IL-8) were measured.
T9 928-1058 Sentence denotes Chi square, Fisher exact, Mann-Whitney U-tests, ROC curve analysis and forward stepwise logistic regression analyses were applied.
T10 1059-1067 Sentence denotes RESULTS:
T11 1068-1230 Sentence denotes Patients with HCC had higher serum TPO and chemokines (P<0.001 for TPO, CCL4, CCL5 and CXCL5) and lower CCL2 (P=0.008) levels than cirrhotic patients without HCC.
T12 1231-1403 Sentence denotes Multivariate forward stepwise regression analysis for significant parameters showed that among the studied parameters CCL4 and CCL5 (P=0.001) are diagnostic markers of HCC.
T13 1404-1522 Sentence denotes Serum levels of TPO and chemokines were lower, whereas M30 was significantly higher in cirrhotic patients than in HCs.
T14 1523-1535 Sentence denotes CONCLUSIONS:
T15 1536-1667 Sentence denotes High serum levels of inflammatory chemokines such as CCL4 and CCL5 in the serum of cirrhotic patients indicate the presence of HCC.

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T9 928-1058 Sentence denotes Chi square, Fisher exact, Mann-Whitney U-tests, ROC curve analysis and forward stepwise logistic regression analyses were applied.
T1 0-113 Sentence denotes Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
T2 114-125 Sentence denotes BACKGROUND:
T3 126-199 Sentence denotes Most hepatocellular carcinomas (HCCs) are diagnosed at an advanced stage.
T4 200-320 Sentence denotes The prognostic value of serum tumour markers alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) is limited.
T5 321-483 Sentence denotes The aim of our study is to evaluate the diagnostic value of serum growth factors, apoptotic and inflammatory mediators of cirrhotic patients with and without HCC.
T6 484-492 Sentence denotes METHODS:
T7 493-659 Sentence denotes Serum samples were collected from cirrhotic potential liver transplant patients (LTx) with (n=61) and without HCC (n=78) as well as from healthy controls (HCs; n=39).
T8 660-927 Sentence denotes Serum concentrations of CRP, neopterin and IL-6 as markers of inflammation and thrombopoietin (TPO), GCSF, FGF basic and VEGF, HMGB1, CK-18 (M65) and CK18 fragment (M30) and a panel of proinflammatory chemokines (CCL2, CCL3, CCL4, CCL5, CXCL5 and IL-8) were measured.
T10 1059-1067 Sentence denotes RESULTS:
T11 1068-1230 Sentence denotes Patients with HCC had higher serum TPO and chemokines (P<0.001 for TPO, CCL4, CCL5 and CXCL5) and lower CCL2 (P=0.008) levels than cirrhotic patients without HCC.
T12 1231-1403 Sentence denotes Multivariate forward stepwise regression analysis for significant parameters showed that among the studied parameters CCL4 and CCL5 (P=0.001) are diagnostic markers of HCC.
T13 1404-1522 Sentence denotes Serum levels of TPO and chemokines were lower, whereas M30 was significantly higher in cirrhotic patients than in HCs.
T14 1523-1535 Sentence denotes CONCLUSIONS:
T15 1536-1667 Sentence denotes High serum levels of inflammatory chemokines such as CCL4 and CCL5 in the serum of cirrhotic patients indicate the presence of HCC.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 940-946 OrganismTaxon denotes Fisher NCBItxid:76720

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
10751 16-26 GeneOrGeneProduct denotes chemokines NCBIGene:3576|NCBIGene:6347|NCBIGene:6348|NCBIGene:6351|NCBIGene:6352|NCBIGene:6374
10752 27-31 GeneOrGeneProduct denotes CCL4 NCBIGene:6351
10753 36-40 GeneOrGeneProduct denotes CCL5 NCBIGene:6352
10754 44-53 DiseaseOrPhenotypicFeature denotes cirrhotic MESH:D008103
10755 54-62 OrganismTaxon denotes patients NCBITaxon:9606
10756 88-112 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma MESH:D006528
10757 131-156 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas MESH:D006528
10758 158-162 DiseaseOrPhenotypicFeature denotes HCCs MESH:D006528
10759 230-236 DiseaseOrPhenotypicFeature denotes tumour MESH:D009369
10760 245-262 GeneOrGeneProduct denotes alpha-fetoprotein NCBIGene:174
10761 264-267 GeneOrGeneProduct denotes AFP NCBIGene:174
10762 273-302 GeneOrGeneProduct denotes des-gamma-carboxy prothrombin NCBIGene:2147
10763 304-307 GeneOrGeneProduct denotes DCP NCBIGene:2147
10764 417-429 DiseaseOrPhenotypicFeature denotes inflammatory MESH:D007249
10765 443-452 DiseaseOrPhenotypicFeature denotes cirrhotic MESH:D008103
10766 453-461 OrganismTaxon denotes patients NCBITaxon:9606
10767 479-482 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528
10768 527-536 DiseaseOrPhenotypicFeature denotes cirrhotic MESH:D008103
10769 564-572 OrganismTaxon denotes patients NCBITaxon:9606
10770 603-606 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528
10771 684-687 GeneOrGeneProduct denotes CRP NCBIGene:1401
10772 689-698 ChemicalEntity denotes neopterin MESH:D019798
10773 703-707 GeneOrGeneProduct denotes IL-6 NCBIGene:3569
10774 722-734 DiseaseOrPhenotypicFeature denotes inflammation MESH:D007249
10775 739-753 GeneOrGeneProduct denotes thrombopoietin NCBIGene:7066
10776 755-758 GeneOrGeneProduct denotes TPO NCBIGene:7066
10777 761-765 GeneOrGeneProduct denotes GCSF NCBIGene:1440
10778 767-776 GeneOrGeneProduct denotes FGF basic NCBIGene:2247
10779 781-785 GeneOrGeneProduct denotes VEGF NCBIGene:7422
10780 787-792 GeneOrGeneProduct denotes HMGB1 NCBIGene:3146
10781 794-799 GeneOrGeneProduct denotes CK-18 NCBIGene:3875
10782 810-814 GeneOrGeneProduct denotes CK18 NCBIGene:3875
10783 845-871 GeneOrGeneProduct denotes proinflammatory chemokines NCBIGene:3576|NCBIGene:6347|NCBIGene:6348|NCBIGene:6351|NCBIGene:6352|NCBIGene:6374
10784 873-877 GeneOrGeneProduct denotes CCL2 NCBIGene:6347
10785 879-883 GeneOrGeneProduct denotes CCL3 NCBIGene:6348
10786 885-889 GeneOrGeneProduct denotes CCL4 NCBIGene:6351
10787 891-895 GeneOrGeneProduct denotes CCL5 NCBIGene:6352
10788 897-902 GeneOrGeneProduct denotes CXCL5 NCBIGene:6374
10789 907-911 GeneOrGeneProduct denotes IL-8 NCBIGene:3576
10790 1068-1076 OrganismTaxon denotes Patients NCBITaxon:9606
10791 1082-1085 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528
10792 1103-1106 GeneOrGeneProduct denotes TPO NCBIGene:7066
10793 1111-1121 GeneOrGeneProduct denotes chemokines NCBIGene:3576|NCBIGene:6347|NCBIGene:6348|NCBIGene:6351|NCBIGene:6352|NCBIGene:6374
10794 1135-1138 GeneOrGeneProduct denotes TPO NCBIGene:7066
10795 1140-1144 GeneOrGeneProduct denotes CCL4 NCBIGene:6351
10796 1146-1150 GeneOrGeneProduct denotes CCL5 NCBIGene:6352
10797 1155-1160 GeneOrGeneProduct denotes CXCL5 NCBIGene:6374
10798 1172-1176 GeneOrGeneProduct denotes CCL2 NCBIGene:6347
10799 1199-1208 DiseaseOrPhenotypicFeature denotes cirrhotic MESH:D008103
10800 1209-1217 OrganismTaxon denotes patients NCBITaxon:9606
10801 1226-1229 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528
10802 1349-1353 GeneOrGeneProduct denotes CCL4 NCBIGene:6351
10803 1358-1362 GeneOrGeneProduct denotes CCL5 NCBIGene:6352
10804 1399-1402 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528
10805 1420-1423 GeneOrGeneProduct denotes TPO NCBIGene:7066
10806 1428-1438 GeneOrGeneProduct denotes chemokines NCBIGene:3576|NCBIGene:6347|NCBIGene:6348|NCBIGene:6351|NCBIGene:6352|NCBIGene:6374
10807 1491-1500 DiseaseOrPhenotypicFeature denotes cirrhotic MESH:D008103
10808 1501-1509 OrganismTaxon denotes patients NCBITaxon:9606
10809 1557-1569 DiseaseOrPhenotypicFeature denotes inflammatory MESH:D007249
10810 1570-1580 GeneOrGeneProduct denotes chemokines NCBIGene:3576|NCBIGene:6347|NCBIGene:6348|NCBIGene:6351|NCBIGene:6352|NCBIGene:6374
10811 1589-1593 GeneOrGeneProduct denotes CCL4 NCBIGene:6351
10812 1598-1602 GeneOrGeneProduct denotes CCL5 NCBIGene:6352
10813 1619-1628 DiseaseOrPhenotypicFeature denotes cirrhotic MESH:D008103
10814 1629-1637 OrganismTaxon denotes patients NCBITaxon:9606
10815 1663-1666 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 88-112 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma 0007256
T2 103-112 DiseaseOrPhenotypicFeature denotes carcinoma 0004993
T3 131-156 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas 0007256

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 16-26 GeneOrGeneProduct denotes chemokines
T2 27-31 GeneOrGeneProduct denotes CCL4
T3 36-40 GeneOrGeneProduct denotes CCL5
T4 245-262 GeneOrGeneProduct denotes alpha-fetoprotein
T5 264-267 GeneOrGeneProduct denotes AFP
T6 277-282 GeneOrGeneProduct denotes gamma
T7 291-302 GeneOrGeneProduct denotes prothrombin
T8 312-319 GeneOrGeneProduct denotes limited
T9 387-401 GeneOrGeneProduct denotes growth factors
T10 547-552 GeneOrGeneProduct denotes liver
T11 703-707 GeneOrGeneProduct denotes IL-6
T12 739-753 GeneOrGeneProduct denotes thrombopoietin
T13 755-758 GeneOrGeneProduct denotes TPO
T14 761-765 GeneOrGeneProduct denotes GCSF
T15 781-785 GeneOrGeneProduct denotes VEGF
T16 787-792 GeneOrGeneProduct denotes HMGB1
T17 794-799 GeneOrGeneProduct denotes CK-18
T18 810-814 GeneOrGeneProduct denotes CK18
T19 861-871 GeneOrGeneProduct denotes chemokines
T20 873-877 GeneOrGeneProduct denotes CCL2
T21 879-883 GeneOrGeneProduct denotes CCL3
T22 885-889 GeneOrGeneProduct denotes CCL4
T23 891-895 GeneOrGeneProduct denotes CCL5
T24 897-902 GeneOrGeneProduct denotes CXCL5
T25 907-911 GeneOrGeneProduct denotes IL-8
T26 932-938 GeneOrGeneProduct denotes square
T27 1103-1106 GeneOrGeneProduct denotes TPO
T28 1111-1121 GeneOrGeneProduct denotes chemokines
T29 1135-1138 GeneOrGeneProduct denotes TPO
T30 1140-1144 GeneOrGeneProduct denotes CCL4
T31 1146-1150 GeneOrGeneProduct denotes CCL5
T32 1155-1160 GeneOrGeneProduct denotes CXCL5
T33 1172-1176 GeneOrGeneProduct denotes CCL2
T34 1349-1353 GeneOrGeneProduct denotes CCL4
T35 1358-1362 GeneOrGeneProduct denotes CCL5
T36 1420-1423 GeneOrGeneProduct denotes TPO
T37 1428-1438 GeneOrGeneProduct denotes chemokines
T38 1570-1580 GeneOrGeneProduct denotes chemokines
T39 1589-1593 GeneOrGeneProduct denotes CCL4
T40 1598-1602 GeneOrGeneProduct denotes CCL5

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 16-26 GeneOrGeneProduct denotes chemokines
T2 27-31 GeneOrGeneProduct denotes CCL4
T3 36-40 GeneOrGeneProduct denotes CCL5
T4 158-162 GeneOrGeneProduct denotes HCCs
T5 215-220 GeneOrGeneProduct denotes value
T6 245-262 GeneOrGeneProduct denotes alpha-fetoprotein
T7 264-267 GeneOrGeneProduct denotes AFP
T8 277-282 GeneOrGeneProduct denotes gamma
T9 291-302 GeneOrGeneProduct denotes prothrombin
T10 312-319 GeneOrGeneProduct denotes limited
T11 372-377 GeneOrGeneProduct denotes value
T12 387-401 GeneOrGeneProduct denotes growth factors
T13 430-439 GeneOrGeneProduct denotes mediators
T14 484-491 GeneOrGeneProduct denotes METHODS
T15 547-552 GeneOrGeneProduct denotes liver
T16 608-612 GeneOrGeneProduct denotes n=78
T17 703-707 GeneOrGeneProduct denotes IL-6
T18 739-753 GeneOrGeneProduct denotes thrombopoietin
T19 755-758 GeneOrGeneProduct denotes TPO
T20 761-765 GeneOrGeneProduct denotes GCSF
T21 767-770 GeneOrGeneProduct denotes FGF
T22 781-785 GeneOrGeneProduct denotes VEGF
T23 787-792 GeneOrGeneProduct denotes HMGB1
T24 794-799 GeneOrGeneProduct denotes CK-18
T25 810-814 GeneOrGeneProduct denotes CK18
T26 861-871 GeneOrGeneProduct denotes chemokines
T27 873-877 GeneOrGeneProduct denotes CCL2
T28 879-883 GeneOrGeneProduct denotes CCL3
T29 885-889 GeneOrGeneProduct denotes CCL4
T30 891-895 GeneOrGeneProduct denotes CCL5
T31 897-902 GeneOrGeneProduct denotes CXCL5
T32 907-911 GeneOrGeneProduct denotes IL-8
T33 932-938 GeneOrGeneProduct denotes square
T34 969-974 GeneOrGeneProduct denotes tests
T35 980-985 GeneOrGeneProduct denotes curve
T36 1103-1106 GeneOrGeneProduct denotes TPO
T37 1111-1121 GeneOrGeneProduct denotes chemokines
T38 1135-1138 GeneOrGeneProduct denotes TPO
T39 1140-1144 GeneOrGeneProduct denotes CCL4
T40 1146-1150 GeneOrGeneProduct denotes CCL5
T41 1155-1160 GeneOrGeneProduct denotes CXCL5
T42 1172-1176 GeneOrGeneProduct denotes CCL2
T43 1349-1353 GeneOrGeneProduct denotes CCL4
T44 1358-1362 GeneOrGeneProduct denotes CCL5
T45 1420-1423 GeneOrGeneProduct denotes TPO
T46 1428-1438 GeneOrGeneProduct denotes chemokines
T47 1536-1540 GeneOrGeneProduct denotes High
T48 1570-1580 GeneOrGeneProduct denotes chemokines
T49 1589-1593 GeneOrGeneProduct denotes CCL4
T50 1598-1602 GeneOrGeneProduct denotes CCL5

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 44-53 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T2 88-112 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma D006528
T3 131-156 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas D006528
T4 158-162 DiseaseOrPhenotypicFeature denotes HCCs D006528
T5 230-236 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T6 417-429 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T7 443-452 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T8 479-482 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T9 527-536 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T10 603-606 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T11 722-734 DiseaseOrPhenotypicFeature denotes inflammation D007249
T12 845-860 DiseaseOrPhenotypicFeature denotes proinflammatory DISEASE
T13 1082-1085 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T14 1199-1208 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T15 1226-1229 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T16 1399-1402 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T17 1491-1500 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T18 1557-1569 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T19 1619-1628 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T20 1663-1666 DiseaseOrPhenotypicFeature denotes HCC DISEASE

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 16-26 GeneOrGeneProduct denotes chemokines
T2 27-31 GeneOrGeneProduct denotes CCL4
T3 36-40 GeneOrGeneProduct denotes CCL5
T4 245-262 GeneOrGeneProduct denotes alpha-fetoprotein
T5 264-267 GeneOrGeneProduct denotes AFP
T6 291-302 GeneOrGeneProduct denotes prothrombin
T7 387-401 GeneOrGeneProduct denotes growth factors
T8 703-707 GeneOrGeneProduct denotes IL-6
T9 739-753 GeneOrGeneProduct denotes thrombopoietin
T10 755-758 GeneOrGeneProduct denotes TPO
T11 761-765 GeneOrGeneProduct denotes GCSF
T12 781-785 GeneOrGeneProduct denotes VEGF
T13 787-792 GeneOrGeneProduct denotes HMGB1
T14 794-799 GeneOrGeneProduct denotes CK-18
T15 810-814 GeneOrGeneProduct denotes CK18
T16 861-871 GeneOrGeneProduct denotes chemokines
T17 873-877 GeneOrGeneProduct denotes CCL2
T18 879-883 GeneOrGeneProduct denotes CCL3
T19 885-889 GeneOrGeneProduct denotes CCL4
T20 891-895 GeneOrGeneProduct denotes CCL5
T21 897-902 GeneOrGeneProduct denotes CXCL5
T22 907-911 GeneOrGeneProduct denotes IL-8
T23 1103-1106 GeneOrGeneProduct denotes TPO
T24 1111-1121 GeneOrGeneProduct denotes chemokines
T25 1135-1138 GeneOrGeneProduct denotes TPO
T26 1140-1144 GeneOrGeneProduct denotes CCL4
T27 1146-1150 GeneOrGeneProduct denotes CCL5
T28 1155-1160 GeneOrGeneProduct denotes CXCL5
T29 1172-1176 GeneOrGeneProduct denotes CCL2
T30 1349-1353 GeneOrGeneProduct denotes CCL4
T31 1358-1362 GeneOrGeneProduct denotes CCL5
T32 1420-1423 GeneOrGeneProduct denotes TPO
T33 1428-1438 GeneOrGeneProduct denotes chemokines
T34 1570-1580 GeneOrGeneProduct denotes chemokines
T35 1589-1593 GeneOrGeneProduct denotes CCL4
T36 1598-1602 GeneOrGeneProduct denotes CCL5

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 88-112 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma 0007256
T2 131-156 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas 0007256
T3 158-162 DiseaseOrPhenotypicFeature denotes HCCs 0007256
T4 264-267 DiseaseOrPhenotypicFeature denotes AFP 0018362
T5 479-482 DiseaseOrPhenotypicFeature denotes HCC 0007256
T6 603-606 DiseaseOrPhenotypicFeature denotes HCC 0007256
T7 794-796 DiseaseOrPhenotypicFeature denotes CK 0017941
T8 1082-1085 DiseaseOrPhenotypicFeature denotes HCC 0007256
T9 1226-1229 DiseaseOrPhenotypicFeature denotes HCC 0007256
T10 1399-1402 DiseaseOrPhenotypicFeature denotes HCC 0007256
T11 1663-1666 DiseaseOrPhenotypicFeature denotes HCC 0007256

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 44-53 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T2 88-112 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma D006528
T3 131-156 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas D006528
T4 158-162 DiseaseOrPhenotypicFeature denotes HCCs D006528
T5 230-236 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T6 417-429 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T7 443-452 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T8 479-482 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T9 527-536 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T10 603-606 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T11 722-734 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249
T13 845-860 DiseaseOrPhenotypicFeature denotes proinflammatory DISEASE
T14 1082-1085 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T15 1199-1208 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T16 1226-1229 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T17 1399-1402 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T18 1491-1500 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T19 1557-1569 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T20 1619-1628 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T21 1663-1666 DiseaseOrPhenotypicFeature denotes HCC DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 44-53 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T2 88-112 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma D006528
T3 131-156 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas D006528
T4 158-162 DiseaseOrPhenotypicFeature denotes HCCs D006528
T5 230-236 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T6 443-452 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T7 479-482 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T8 527-536 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T9 603-606 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T10 722-734 DiseaseOrPhenotypicFeature denotes inflammation D007249
T11 845-860 DiseaseOrPhenotypicFeature denotes proinflammatory DISEASE
T12 1082-1085 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T13 1199-1208 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T14 1226-1229 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T15 1399-1402 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T16 1491-1500 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T17 1619-1628 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T18 1663-1666 DiseaseOrPhenotypicFeature denotes HCC DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 273-302 ChemicalEntity denotes des-gamma-carboxy prothrombin C008208
T2 304-307 ChemicalEntity denotes DCP http://purl.obolibrary.org/obo/CHEBI_60424
T3 689-698 ChemicalEntity denotes neopterin D019798|http://purl.obolibrary.org/obo/CHEBI_28670
T5 897-902 ChemicalEntity denotes CXCL5 http://purl.obolibrary.org/obo/CHEBI_138180
T6 1155-1160 ChemicalEntity denotes CXCL5 http://purl.obolibrary.org/obo/CHEBI_138180

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 54-62 OrganismTaxon denotes patients
T2 453-461 OrganismTaxon denotes patients
T3 564-572 OrganismTaxon denotes patients
T4 940-946 OrganismTaxon denotes Fisher
T5 1209-1217 OrganismTaxon denotes patients
T6 1501-1509 OrganismTaxon denotes patients
T7 1629-1637 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T6 1155-1160 ChemicalEntity denotes CXCL5 http://purl.obolibrary.org/obo/CHEBI_138180
T5 897-902 ChemicalEntity denotes CXCL5 http://purl.obolibrary.org/obo/CHEBI_138180
T3 689-698 ChemicalEntity denotes neopterin http://purl.obolibrary.org/obo/CHEBI_28670|D019798
T2 304-307 ChemicalEntity denotes DCP http://purl.obolibrary.org/obo/CHEBI_60424
T1 273-302 ChemicalEntity denotes des-gamma-carboxy prothrombin C008208
T36 1598-1602 GeneOrGeneProduct denotes CCL5
T35 1589-1593 GeneOrGeneProduct denotes CCL4
T34 1570-1580 GeneOrGeneProduct denotes chemokines
T33 1428-1438 GeneOrGeneProduct denotes chemokines
T32 1420-1423 GeneOrGeneProduct denotes TPO
T31 1358-1362 GeneOrGeneProduct denotes CCL5
T30 1349-1353 GeneOrGeneProduct denotes CCL4
T29 1172-1176 GeneOrGeneProduct denotes CCL2
T28 1155-1160 GeneOrGeneProduct denotes CXCL5
T27 1146-1150 GeneOrGeneProduct denotes CCL5
T26 1140-1144 GeneOrGeneProduct denotes CCL4
T25 1135-1138 GeneOrGeneProduct denotes TPO
T24 1111-1121 GeneOrGeneProduct denotes chemokines
T23 1103-1106 GeneOrGeneProduct denotes TPO
T22 907-911 GeneOrGeneProduct denotes IL-8
T21 897-902 GeneOrGeneProduct denotes CXCL5
T20 891-895 GeneOrGeneProduct denotes CCL5
T19 885-889 GeneOrGeneProduct denotes CCL4
T18 879-883 GeneOrGeneProduct denotes CCL3
T17 873-877 GeneOrGeneProduct denotes CCL2
T16 861-871 GeneOrGeneProduct denotes chemokines
T15 810-814 GeneOrGeneProduct denotes CK18
T14 794-799 GeneOrGeneProduct denotes CK-18
T13 787-792 GeneOrGeneProduct denotes HMGB1
T12 781-785 GeneOrGeneProduct denotes VEGF
T11 761-765 GeneOrGeneProduct denotes GCSF
T10 755-758 GeneOrGeneProduct denotes TPO
T9 739-753 GeneOrGeneProduct denotes thrombopoietin
T8 703-707 GeneOrGeneProduct denotes IL-6
T7 387-401 GeneOrGeneProduct denotes growth factors
T48779 291-302 GeneOrGeneProduct denotes prothrombin
T74159 264-267 GeneOrGeneProduct denotes AFP
T4 245-262 GeneOrGeneProduct denotes alpha-fetoprotein
T14246 36-40 GeneOrGeneProduct denotes CCL5
T99924 27-31 GeneOrGeneProduct denotes CCL4
T81739 16-26 GeneOrGeneProduct denotes chemokines
T49681 1663-1666 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T22912 1619-1628 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T84869 1491-1500 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T72555 1399-1402 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T81757 1226-1229 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T17282 1199-1208 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T80180 1082-1085 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T19134 845-860 DiseaseOrPhenotypicFeature denotes proinflammatory DISEASE
T48125 722-734 DiseaseOrPhenotypicFeature denotes inflammation D007249
T36345 603-606 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T36329 527-536 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T64429 479-482 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T78749 443-452 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T4897 230-236 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T11056 158-162 DiseaseOrPhenotypicFeature denotes HCCs D006528
T10763 131-156 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas D006528
T18562 88-112 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma D006528
T70302 44-53 DiseaseOrPhenotypicFeature denotes cirrhotic DISEASE
T89211 1629-1637 OrganismTaxon denotes patients
T39695 1501-1509 OrganismTaxon denotes patients
T61674 1209-1217 OrganismTaxon denotes patients
T63685 940-946 OrganismTaxon denotes Fisher
T46780 564-572 OrganismTaxon denotes patients
T23620 453-461 OrganismTaxon denotes patients
T81421 54-62 OrganismTaxon denotes patients